International Summit on Hematology and Blood Disorders

April 27-29, 2023

April 27 -29, 2023 | Online Event

Blood based products

Blood based products

Any therapeutic substance obtained from human blood, including whole blood and other blood components for transfusion, as well as plasma-derived pharmaceutical compounds, is referred to as a blood product. Medicinal (medical therapeutic) products obtained from human blood and plasma donations play an important role in medical care. Every year, blood products that are safe, effective, and of high-quality help to improve and save millions of lives. Inadequate or unsafe blood supplies have a detrimental influence on the ability of critical health services and programmes to offer proper patient care in a variety of acute and chronic illnesses. Access to safe, effective, and quality-assured blood products for all patients who require transfusion is a critical component of a functional health system and essential for patient safety.

Committee Members
Speaker at Hematology and Blood Disorders 2023 - Stefan Gluck

Stefan Gluck

Global Medical Affairs at Celgene Corporation, United States
Speaker at Hematology and Blood Disorders 2023 - A C Matin

A C Matin

Stanford Medical School, United States
Speaker at Hematology and Blood Disorders 2023 - Mohamed Alsharedi

Mohamed Alsharedi

Markey Cancer Center at Lexington Clinic, United States
Hematology 2023 Speakers
Speaker at Hematology and Blood Disorders 2023 - Sanghoon Lee

Sanghoon Lee

Marshall University, United States
Speaker at Hematology and Blood Disorders 2023 - Stefan Gluck

Stefan Gluck

Global Medical Affairs at Celgene Corporation, United States
Speaker at Hematology and Blood Disorders 2023 - Erin Weigel

Erin Weigel

Kedrion Biopharma, United States
Speaker at Hematology and Blood Disorders 2023 - Brandon Lucke Wold

Brandon Lucke Wold

University of Florida, United States

Submit your abstract Today

Watsapp